Related Experiment Video
Updated: Jul 2, 2026

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
[Immune-mediated encephalitis in a child with a history of SARS-CoV-2 infection]
Jhoanna Adauto Luizaga1, Florencia Costa Almar1, Agustina Zwirner1
1Clínica Pediátrica, Hospital de Niños Dr. Ricardo Gutiérrez, Ciudad Autónoma de Buenos Aires, Argentina.
Insights
A recent SARS-CoV-2 infection may trigger anti-NMDAR antibody encephalitis in children. This case study explores the potential link between viral infections and autoimmune neurological disorders in pediatric patients.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- Encephalitis is common in children, with infectious and immune-mediated causes.
- The SARS-CoV-2 pandemic has presented diverse clinical manifestations in children, including neurological symptoms and MIS-C.
- Anti-NMDAR antibody encephalitis is a significant autoimmune neurological disorder.
Observation:
- A 2-year-old boy was diagnosed with anti-NMDAR antibody encephalitis.
- Serological tests confirmed a recent SARS-CoV-2 infection in the patient.
- The patient presented with symptoms consistent with encephalitis.
Findings:
- The case demonstrates a temporal association between SARS-CoV-2 infection and anti-NMDAR antibody encephalitis.
- Serological evidence suggests a possible link between the virus and the autoimmune condition.
- This finding supports the hypothesis of viral triggers for autoimmune diseases.
Implications:
- SARS-CoV-2 may act as a trigger for autoimmune encephalitis in susceptible pediatric populations.
- Understanding this association can aid in early diagnosis and management of post-infectious autoimmune neurological disorders.
- Further research is needed to elucidate the precise mechanisms linking SARS-CoV-2 to anti-NMDAR antibody encephalitis.
Abstract:
Encephalitis are frequent clinical pictures in pediatric age. They can be divided into those caused by infection of the central nervous system and those of immune-mediated etiology (some of which may be para- or post-infectious). In March 2020, the WHO declared a SARS-CoV-2 pandemic. Pediatric reports of disease caused by this agent describe a wide range of clinical manifestations: respiratory and gastrointestinal compromise, neurological symptoms, among others; and a multisystemic inflammatory syndrome in children associated with COVID-19 (MIS-C). We describe the case of a 2-year-old boy with a diagnosis of anti-NMDAR antibody encephalitis, in whom a recent SARS-CoV-2 infection was serologically proven. The presence of positive serological markers for SARS-CoV-2 in a patient who presented encephalitis due to anti-NMDAR antibodies could be interpreted as a temporal association; establishing the possibility that the virus has acted as a trigger for an autoimmune disease.
More Related Videos
08:44Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
09:37Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Related Concept Videos
Viral Meningitis
Arboviral Encephalitis
Coronavirus
Respiratory Syncytial Virus Disease
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology